Logo image of NCZ

VIRTUS CONVERTIBLE & INCOME (NCZ) Stock Price, Quote, News and Overview

NYSE:NCZ - New York Stock Exchange, Inc. - US92838U8018 - Currency: USD

11.51  +0.19 (+1.68%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NCZ. NCZ was compared to 0 industry peers in the Unkown industry. NCZ may be in some trouble as it scores bad on both profitability and health. NCZ does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

NCZ had positive earnings in the past year.
NCZ had a positive operating cash flow in the past year.
In multiple years NCZ reported negative net income over the last 5 years.
In the past 5 years NCZ reported 4 times negative operating cash flow.
NCZ Yearly Net Income VS EBIT VS OCF VS FCFNCZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA 1.14%
ROE 1.3%
ROIC 2.1%
ROA(3y)0.4%
ROA(5y)0.55%
ROE(3y)-0.8%
ROE(5y)-0.18%
ROIC(3y)2.42%
ROIC(5y)3.27%
NCZ Yearly ROA, ROE, ROICNCZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

NCZ's Profit Margin has declined in the last couple of years.
NCZ's Operating Margin has declined in the last couple of years.
NCZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 60.26%
PM (TTM) 26.27%
GM 60.79%
OM growth 3Y-10.8%
OM growth 5Y-6.97%
PM growth 3Y-48.84%
PM growth 5Y-34.06%
GM growth 3Y-8.95%
GM growth 5Y-5.78%
NCZ Yearly Profit, Operating, Gross MarginsNCZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

2

2. Health

2.1 Basic Checks

NCZ has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for NCZ has been increased compared to 5 years ago.
NCZ has a better debt/assets ratio than last year.
NCZ Yearly Shares OutstandingNCZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NCZ Yearly Total Debt VS Total AssetsNCZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that NCZ is in the distress zone and has some risk of bankruptcy.
NCZ has a debt to FCF ratio of 3.59. This is a good value and a sign of high solvency as NCZ would need 3.59 years to pay back of all of its debts.
A Debt/Equity ratio of 0.12 indicates that NCZ is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.59
Altman-Z 1.77
ROIC/WACCN/A
WACCN/A
NCZ Yearly LT Debt VS Equity VS FCFNCZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.81 indicates that NCZ may have some problems paying its short term obligations.
A Quick Ratio of 0.81 indicates that NCZ may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
NCZ Yearly Current Assets VS Current LiabilitesNCZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.57% over the past year.
The earnings per share for NCZ have been decreasing by -46.56% on average. This is quite bad
Looking at the last year, NCZ shows a decrease in Revenue. The Revenue has decreased by -6.24% in the last year.
NCZ shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -18.86% yearly.
EPS 1Y (TTM)101.57%
EPS 3Y-61.06%
EPS 5Y-46.56%
EPS Q2Q%-113.5%
Revenue 1Y (TTM)-6.24%
Revenue growth 3Y-24.06%
Revenue growth 5Y-18.86%
Sales Q2Q%-5.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCZ Yearly Revenue VS EstimatesNCZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1151.00, NCZ can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of NCZ to the average of the S&P500 Index (28.92), we can say NCZ is valued expensively.
Industry RankSector Rank
PE 1151
Fwd PE N/A
NCZ Price Earnings VS Forward Price EarningsNCZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 16.73
EV/EBITDA N/A
NCZ Per share dataNCZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.01%, NCZ is a good candidate for dividend investing.
NCZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 7.01%

5.2 History

NCZ has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NCZ Yearly Dividends per shareNCZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

NCZ pays out 814.20% of its income as dividend. This is not a sustainable payout ratio.
DP814.2%
EPS Next 2YN/A
EPS Next 3YN/A
NCZ Yearly Income VS Free CF VS DividendNCZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
NCZ Dividend Payout.NCZ Dividend Payout, showing the Payout Ratio.NCZ Dividend Payout.PayoutRetained Earnings

VIRTUS CONVERTIBLE & INCOME

NYSE:NCZ (4/24/2025, 8:04:00 PM)

11.51

+0.19 (+1.68%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners34.58%
Inst Owner Change-3.38%
Ins Owners0.01%
Ins Owner Change0%
Market Cap219.04M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield 7.01%
Yearly Dividend0.45
Dividend Growth(5Y)N/A
DP814.2%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-12 2025-06-12 (0.12)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1151
Fwd PE N/A
P/S 11.67
P/FCF 16.73
P/OCF 16.73
P/B 0.58
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)0.01
EY0.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.69
FCFY5.98%
OCF(TTM)0.69
OCFY5.98%
SpS0.99
BVpS19.86
TBVpS19.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.14%
ROE 1.3%
ROCE 2.83%
ROIC 2.1%
ROICexc 2.2%
ROICexgc 2.2%
OM 60.26%
PM (TTM) 26.27%
GM 60.79%
FCFM 69.74%
ROA(3y)0.4%
ROA(5y)0.55%
ROE(3y)-0.8%
ROE(5y)-0.18%
ROIC(3y)2.42%
ROIC(5y)3.27%
ROICexc(3y)2.53%
ROICexc(5y)3.44%
ROICexgc(3y)2.53%
ROICexgc(5y)3.44%
ROCE(3y)3.37%
ROCE(5y)4.33%
ROICexcg growth 3Y-23.98%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-23.98%
ROICexc growth 5Y-15.4%
OM growth 3Y-10.8%
OM growth 5Y-6.97%
PM growth 3Y-48.84%
PM growth 5Y-34.06%
GM growth 3Y-8.95%
GM growth 5Y-5.78%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.59
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 265.52%
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 1.77
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.57%
EPS 3Y-61.06%
EPS 5Y-46.56%
EPS Q2Q%-113.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.24%
Revenue growth 3Y-24.06%
Revenue growth 5Y-18.86%
Sales Q2Q%-5.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-40.75%
EBIT growth 3Y-32.26%
EBIT growth 5Y-24.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y111.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y111.97%
OCF growth 3YN/A
OCF growth 5YN/A